StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a report issued on Tuesday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Price Performance

CUTR opened at $0.04 on Tuesday. Cutera has a 1 year low of $0.09 and a 1 year high of $3.00. The stock has a 50-day moving average price of $0.36 and a 200-day moving average price of $0.48. The firm has a market cap of $787,254.00, a PE ratio of -0.01 and a beta of 1.36.

Institutional Investors Weigh In On Cutera

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP acquired a new position in Cutera, Inc. (NASDAQ:CUTR) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned approximately 0.82% of Cutera as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.